The Council for Medical Schemes (CMS) has responded to Michael Avery’s recent column titled “Anatomy of a scandal: Bonitas said to have lost Sanlam’s trust” (October 14), which questioned the regulatory body’s oversight and raised concerns about long-standing contracts in the medical scheme industry. Avery’s article insinuated that the CMS has been passive as a regulator. However, the CMS pointed…